360 related articles for article (PubMed ID: 33202621)
21. A standardized herbal combination of Astragalus membranaceus and Paeonia japonica, protects against muscle atrophy in a C26 colon cancer cachexia mouse model.
Lee SB; Lee JS; Moon SO; Lee HD; Yoon YS; Son CG
J Ethnopharmacol; 2021 Mar; 267():113470. PubMed ID: 33068652
[TBL] [Abstract][Full Text] [Related]
22. Nuclear magnetic resonance in conjunction with functional genomics suggests mitochondrial dysfunction in a murine model of cancer cachexia.
Constantinou C; Fontes de Oliveira CC; Mintzopoulos D; Busquets S; He J; Kesarwani M; Mindrinos M; Rahme LG; Argilés JM; Tzika AA
Int J Mol Med; 2011 Jan; 27(1):15-24. PubMed ID: 21069263
[TBL] [Abstract][Full Text] [Related]
23. Control of food intake and muscle wasting in cachexia.
Amitani M; Asakawa A; Amitani H; Inui A
Int J Biochem Cell Biol; 2013 Oct; 45(10):2179-85. PubMed ID: 23911307
[TBL] [Abstract][Full Text] [Related]
24. Impact of cancer cachexia on respiratory muscle function and the therapeutic potential of exercise.
Murphy BT; Mackrill JJ; O'Halloran KD
J Physiol; 2022 Dec; 600(23):4979-5004. PubMed ID: 36251564
[TBL] [Abstract][Full Text] [Related]
25. An update on nutrient modulation in the management of disease-induced muscle wasting: evidence from human studies.
Brook MS; Wilkinson DJ; Atherton PJ
Curr Opin Clin Nutr Metab Care; 2020 May; 23(3):174-180. PubMed ID: 32175954
[TBL] [Abstract][Full Text] [Related]
26. Cancer cachexia: molecular mechanism and pharmacological management.
Li Y; Jin H; Chen Y; Huang T; Mi Y; Zou Z
Biochem J; 2021 May; 478(9):1663-1688. PubMed ID: 33970218
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of FoxO transcriptional activity prevents muscle fiber atrophy during cachexia and induces hypertrophy.
Reed SA; Sandesara PB; Senf SM; Judge AR
FASEB J; 2012 Mar; 26(3):987-1000. PubMed ID: 22102632
[TBL] [Abstract][Full Text] [Related]
28. Aerobic exercise training as therapy for cardiac and cancer cachexia.
Alves CR; da Cunha TF; da Paixão NA; Brum PC
Life Sci; 2015 Mar; 125():9-14. PubMed ID: 25500304
[TBL] [Abstract][Full Text] [Related]
29. Molecular Mechanisms of Cachexia: A Review.
Neshan M; Tsilimigras DI; Han X; Zhu H; Pawlik TM
Cells; 2024 Jan; 13(3):. PubMed ID: 38334644
[TBL] [Abstract][Full Text] [Related]
30. Mitochondrial and sarcoplasmic reticulum abnormalities in cancer cachexia: altered energetic efficiency?
Fontes-Oliveira CC; Busquets S; Toledo M; Penna F; Paz Aylwin M; Sirisi S; Silva AP; Orpí M; García A; Sette A; Inês Genovese M; Olivan M; López-Soriano FJ; Argilés JM
Biochim Biophys Acta; 2013 Mar; 1830(3):2770-8. PubMed ID: 23200745
[TBL] [Abstract][Full Text] [Related]
31. Muscle Atrophy: Present and Future.
Cao RY; Li J; Dai Q; Li Q; Yang J
Adv Exp Med Biol; 2018; 1088():605-624. PubMed ID: 30390273
[TBL] [Abstract][Full Text] [Related]
32. The metabolite butyrate produced by gut microbiota inhibits cachexia-associated skeletal muscle atrophy by regulating intestinal barrier function and macrophage polarization.
Liu H; Xi Q; Tan S; Qu Y; Meng Q; Zhang Y; Cheng Y; Wu G
Int Immunopharmacol; 2023 Nov; 124(Pt B):111001. PubMed ID: 37804658
[TBL] [Abstract][Full Text] [Related]
33. Assessing Metabolic Dysregulation in Muscle During Cachexia.
Hsu MY; Porporato PE; Wyart E
Methods Mol Biol; 2019; 1928():337-352. PubMed ID: 30725463
[TBL] [Abstract][Full Text] [Related]
34. Small-Molecule Chemical Knockdown of MuRF1 in Melanoma Bearing Mice Attenuates Tumor Cachexia Associated Myopathy.
Adams V; Gußen V; Zozulya S; Cruz A; Moriscot A; Linke A; Labeit S
Cells; 2020 Oct; 9(10):. PubMed ID: 33050629
[No Abstract] [Full Text] [Related]
35. Muscle wasting.
Childs SG
Orthop Nurs; 2003; 22(4):251-7; quiz 258-9. PubMed ID: 12961968
[TBL] [Abstract][Full Text] [Related]
36. Loss of strength capacity is associated with mortality, but resistance exercise training promotes only modest effects during cachexia progression.
das Neves W; Alves CR; de Almeida NR; Guimarães FL; Ramires PR; Brum PC; Lancha AH
Life Sci; 2016 Oct; 163():11-22. PubMed ID: 27575705
[TBL] [Abstract][Full Text] [Related]
37. Cancer- and endotoxin-induced cachexia require intact glucocorticoid signaling in skeletal muscle.
Braun TP; Grossberg AJ; Krasnow SM; Levasseur PR; Szumowski M; Zhu XX; Maxson JE; Knoll JG; Barnes AP; Marks DL
FASEB J; 2013 Sep; 27(9):3572-82. PubMed ID: 23733748
[TBL] [Abstract][Full Text] [Related]
38. Valproic acid attenuates skeletal muscle wasting by inhibiting C/EBPβ-regulated atrogin1 expression in cancer cachexia.
Sun R; Zhang S; Hu W; Lu X; Lou N; Yang Z; Chen S; Zhang X; Yang H
Am J Physiol Cell Physiol; 2016 Jul; 311(1):C101-15. PubMed ID: 27122162
[TBL] [Abstract][Full Text] [Related]
39. Muscle Atrophy in Cancer.
Yang J; Cao RY; Li Q; Zhu F
Adv Exp Med Biol; 2018; 1088():329-346. PubMed ID: 30390259
[TBL] [Abstract][Full Text] [Related]
40. Muscle wasting in cardiac cachexia.
Strassburg S; Springer J; Anker SD
Int J Biochem Cell Biol; 2005 Oct; 37(10):1938-47. PubMed ID: 15927519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
